Dark Forest Capital Management’s Standard BioTools LAB Stock Holding History

Dark Forest Capital Management’s Portfolio LAB Stock Details LAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,347	Closed	-$5K	–	1546
2021 Q4	$5K	Buy	1,347 +1,276	+1,797%	+$5.97K	﹤0.01%	1160
2021 Q3	$0	Sell	71 -331	-82%	-$2.18K	﹤0.01%	1414
2021 Q2	$2K	Buy	+402	New	+$2.15K	﹤0.01%	755

Other funds holding LAB

ICM

Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NIM

Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dark Forest Capital Management's LAB Position: Q1 2022 in Review

Dark Forest Capital Management sold out of Standard BioTools (LAB) in Q1 2022, closing a stake of 1,347 shares — an estimated $5K sold.

Dark Forest Capital Management first reported a position in LAB in Q2 2021 and held it in 3 quarters. The position peaked at $5K in Q4 2021. 109 funds tracked by Wall St. Rank hold LAB as of Q1 2022.

Dark Forest Capital Management reported no remaining Standard BioTools position as of Q1 2022 after selling out during the quarter.
Dark Forest Capital Management sold 1,347 Standard BioTools shares in Q1 2022, an estimated $5K.
Dark Forest Capital Management first reported a position in Standard BioTools in Q2 2021 and held it in 3 quarters.
Dark Forest Capital Management's Standard BioTools position peaked at $5K in Q4 2021.
109 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2022.

Based on Dark Forest Capital Management's 13F filing for Q1 2022, filed 13 May 2022.